Global Veterinary Drug Market Size, Share, Trends and Forecast 2022-2030

Description

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
Industry Insights

Due to the COVID-19 pandemic, the global Veterinary Drug market size is estimated to be worth US$ 23720 million in 2021 and is forecast to a readjusted size of US$ 34660 million by 2028 with a CAGR of 5.5% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Veterinary Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Veterinary Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.

This report focuses on Veterinary Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Veterinary Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and Latin America, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Veterinary Drug market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Anti-Infectives

Anti-Inflammatory

Parasiticides

Analgesics

Sedatives

Others

Segment by Application

Pets

Cattle

Poultry

Swine

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Zoetis

Elanco

Boehringer Ingelheim

Merck

Virbac

Ceva

Vetoquinol

Dechra

Norbrook

Phibro

Huvepharma

Hipra

Ouro Fino Saude

CAHIC

Orion

Ringpu Biology

Nippon Zenyaku Kogyo

Farmavet-Pasteur

TABLE OF CONTENT

1 Veterinary Drug Market Overview
1.1 Product Overview and Scope of Veterinary Drug

1.2 Veterinary Drug Segment by Type

1.2.1 Global Veterinary Drug Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Anti-Infectives

1.2.3 Anti-Inflammatory

1.2.4 Parasiticides

1.2.5 Analgesics

1.2.6 Sedatives

1.2.7 Others

1.3 Veterinary Drug Segment by Application

1.3.1 Global Veterinary Drug Sales Comparison by Application: (2022-2028)

1.3.2 Pets

1.3.3 Cattle

1.3.4 Poultry

1.3.5 Swine

1.3.6 Others

1.4 Global Veterinary Drug Market Size Estimates and Forecasts

1.4.1 Global Veterinary Drug Revenue 2017-2028

1.4.2 Global Veterinary Drug Sales 2017-2028

1.4.3 Veterinary Drug Market Size by Region: 2017 Versus 2021 Versus 2028

2 Veterinary Drug Market Competition by Manufacturers

2.1 Global Veterinary Drug Sales Market Share by Manufacturers (2017-2022)

2.2 Global Veterinary Drug Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Veterinary Drug Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Veterinary Drug Manufacturing Sites, Area Served, Product Type

2.5 Veterinary Drug Market Competitive Situation and Trends

2.5.1 Veterinary Drug Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Veterinary Drug Players Market Share by Revenue

2.5.3 Global Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Veterinary Drug Retrospective Market Scenario by Region

3.1 Global Veterinary Drug Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Veterinary Drug Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Veterinary Drug Market Facts & Figures by Country

3.3.1 North America Veterinary Drug Sales by Country

3.3.2 North America Veterinary Drug Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Veterinary Drug Market Facts & Figures by Country

3.4.1 Europe Veterinary Drug Sales by Country

3.4.2 Europe Veterinary Drug Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Veterinary Drug Market Facts & Figures by Region

3.5.1 Asia Pacific Veterinary Drug Sales by Region

3.5.2 Asia Pacific Veterinary Drug Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Veterinary Drug Market Facts & Figures by Country

3.6.1 Latin America Veterinary Drug Sales by Country

3.6.2 Latin America Veterinary Drug Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Veterinary Drug Market Facts & Figures by Country

3.7.1 Middle East and Africa Veterinary Drug Sales by Country

3.7.2 Middle East and Africa Veterinary Drug Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Veterinary Drug Historic Market Analysis by Type

4.1 Global Veterinary Drug Sales Market Share by Type (2017-2022)

4.2 Global Veterinary Drug Revenue Market Share by Type (2017-2022)

4.3 Global Veterinary Drug Price by Type (2017-2022)

5 Global Veterinary Drug Historic Market Analysis by Application

5.1 Global Veterinary Drug Sales Market Share by Application (2017-2022)

5.2 Global Veterinary Drug Revenue Market Share by Application (2017-2022)

5.3 Global Veterinary Drug Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Zoetis

6.1.1 Zoetis Corporation Information

6.1.2 Zoetis Description and Business Overview

6.1.3 Zoetis Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Zoetis Veterinary Drug Product Portfolio

6.1.5 Zoetis Recent Developments/Updates

6.2 Elanco

6.2.1 Elanco Corporation Information

6.2.2 Elanco Description and Business Overview

6.2.3 Elanco Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Elanco Veterinary Drug Product Portfolio

6.2.5 Elanco Recent Developments/Updates

6.3 Boehringer Ingelheim

6.3.1 Boehringer Ingelheim Corporation Information

6.3.2 Boehringer Ingelheim Description and Business Overview

6.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio

6.3.5 Boehringer Ingelheim Recent Developments/Updates

6.4 Merck

6.4.1 Merck Corporation Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Merck Veterinary Drug Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Virbac

6.5.1 Virbac Corporation Information

6.5.2 Virbac Description and Business Overview

6.5.3 Virbac Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Virbac Veterinary Drug Product Portfolio

6.5.5 Virbac Recent Developments/Updates

6.6 Ceva

6.6.1 Ceva Corporation Information

6.6.2 Ceva Description and Business Overview

6.6.3 Ceva Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Ceva Veterinary Drug Product Portfolio

6.6.5 Ceva Recent Developments/Updates

6.7 Vetoquinol

6.6.1 Vetoquinol Corporation Information

6.6.2 Vetoquinol Description and Business Overview

6.6.3 Vetoquinol Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Vetoquinol Veterinary Drug Product Portfolio

6.7.5 Vetoquinol Recent Developments/Updates

6.8 Dechra

6.8.1 Dechra Corporation Information

6.8.2 Dechra Description and Business Overview

6.8.3 Dechra Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Dechra Veterinary Drug Product Portfolio

6.8.5 Dechra Recent Developments/Updates

6.9 Norbrook

6.9.1 Norbrook Corporation Information

6.9.2 Norbrook Description and Business Overview

6.9.3 Norbrook Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Norbrook Veterinary Drug Product Portfolio

6.9.5 Norbrook Recent Developments/Updates

6.10 Phibro

6.10.1 Phibro Corporation Information

6.10.2 Phibro Description and Business Overview

6.10.3 Phibro Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Phibro Veterinary Drug Product Portfolio

6.10.5 Phibro Recent Developments/Updates

6.11 Huvepharma

6.11.1 Huvepharma Corporation Information

6.11.2 Huvepharma Veterinary Drug Description and Business Overview

6.11.3 Huvepharma Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Huvepharma Veterinary Drug Product Portfolio

6.11.5 Huvepharma Recent Developments/Updates

6.12 Hipra

6.12.1 Hipra Corporation Information

6.12.2 Hipra Veterinary Drug Description and Business Overview

6.12.3 Hipra Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Hipra Veterinary Drug Product Portfolio

6.12.5 Hipra Recent Developments/Updates

6.13 Ouro Fino Saude

6.13.1 Ouro Fino Saude Corporation Information

6.13.2 Ouro Fino Saude Veterinary Drug Description and Business Overview

6.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio

6.13.5 Ouro Fino Saude Recent Developments/Updates

6.14 CAHIC

6.14.1 CAHIC Corporation Information

6.14.2 CAHIC Veterinary Drug Description and Business Overview

6.14.3 CAHIC Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.14.4 CAHIC Veterinary Drug Product Portfolio

6.14.5 CAHIC Recent Developments/Updates

6.15 Orion

6.15.1 Orion Corporation Information

6.15.2 Orion Veterinary Drug Description and Business Overview

6.15.3 Orion Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.15.4 Orion Veterinary Drug Product Portfolio

6.15.5 Orion Recent Developments/Updates

6.16 Ringpu Biology

6.16.1 Ringpu Biology Corporation Information

6.16.2 Ringpu Biology Veterinary Drug Description and Business Overview

6.16.3 Ringpu Biology Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.16.4 Ringpu Biology Veterinary Drug Product Portfolio

6.16.5 Ringpu Biology Recent Developments/Updates

6.17 Nippon Zenyaku Kogyo

6.17.1 Nippon Zenyaku Kogyo Corporation Information

6.17.2 Nippon Zenyaku Kogyo Veterinary Drug Description and Business Overview

6.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio

6.17.5 Nippon Zenyaku Kogyo Recent Developments/Updates

6.18 Farmavet-Pasteur

6.18.1 Farmavet-Pasteur Corporation Information

6.18.2 Farmavet-Pasteur Veterinary Drug Description and Business Overview

6.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)

6.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio

6.18.5 Farmavet-Pasteur Recent Developments/Updates

7 Veterinary Drug Manufacturing Cost Analysis

7.1 Veterinary Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Veterinary Drug

7.4 Veterinary Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Veterinary Drug Distributors List

8.3 Veterinary Drug Customers

9 Veterinary Drug Market Dynamics

9.1 Veterinary Drug Industry Trends

9.2 Veterinary Drug Market Drivers

9.3 Veterinary Drug Market Challenges

9.4 Veterinary Drug Market Restraints

10 Global Market Forecast

10.1 Veterinary Drug Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Veterinary Drug by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Veterinary Drug by Type (2023-2028)

10.2 Veterinary Drug Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Veterinary Drug by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Veterinary Drug by Application (2023-2028)

10.3 Veterinary Drug Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Veterinary Drug by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Veterinary Drug by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample